Data and safety monitoring board clears American gene technologies for its HIV cure program

US – American Gene Technologies (AGT) has been cleared by the Data and Safety Monitoring Board (DSMB) under a unanimous vote to continue with its HIV cure program after safety analysis of the participant’s data revealed no adverse effects from the treatment. AGT’s HIV cure program is based on a platform that has the capacity to treat other chronic viral infections, as well as monogenic disorders and cancers. The nod by DBSM gives AGT the confidence to keep pushing for the cure against HIV/AIDS cure. “Safety represents a critical milestone…

Read More